5 Stocks to Watch: Week of 6/1/2026

Happy (almost) June! We've got a stellar list of stocks to watch this week (and all month, really):

• Jazz Pharmaceuticals PLC (JAZZ) — Biotech leader stands out with 28% upside potential.
• Micron Technology Inc (MU) — AI memory king eyes $1,100 target as DRAM surges.
• Tactile Systems Technology (TCMD) — Medical device leader targets 58% upside on FDA wins.
• Atlanticus Holdings (ATLC) — Credit services king eyes 20% upside with 51% ROE.
• Orion Group Holdings (ORN) — Marine infrastructure targets 91% earnings growth ahead.

Let's get to it.

A note from our sponsors...

1- Jazz Pharmaceuticals (NASDAQ: JAZZ)

This biopharmaceutical innovator — developing and commercializing pharmaceutical products for unmet medical needs across the US and Europe — just earned major Wall Street love. UBS raised its price target to $307, and with Strong Buy ratings from 8 of 12 analysts covering the stock, JAZZ is firing on all cylinders as it stands out as the clear leader in its struggling biotech sector.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $235.38 — get current quote

Max 1-year forecast: $307.00

Why we're watching:

• Analyst support: Wall Street analysts are bullish with 8 Strong Buy ratings, 3 Buy ratings, and just 1 Hold rating among the 12 analysts covering JAZZ - delivering a consensus Strong Buy with 91.67% bullish sentiment and zero Sell ratings. See the ratings
• UBS researcher Ashwani Verma (a top 12% rated analyst) recently upgraded Jazz to Strong Buy with a $307 price target following the company's presentation at the RBC Capital Markets Global Healthcare Conference 2026.
• Truist Securities' Joon Lee (a top 2% rated analyst) and Piper Sandler's David Amsellem (a top 5% rated analyst) both maintain Strong Buy ratings, highlighting Jazz's unique positioning in the cannabis pharmaceutical space with its Epidiolex product.
• Industry ranking context: Jazz is currently the #1 highest-rated stock in the Biotech industry, despite the industry having a concerning F rating overall, making Jazz's A rating particularly impressive relative to its 464 industry peers.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — Jazz stands out as the clear leader in its struggling biotech sector.
• Component Grades: Jazz earns top marks with A grades in both Value and Growth, complemented by B grades in Momentum, Sentiment, and Financials, demonstrating strong fundamentals across multiple investment criteria despite C grades in Safety, and Artificial Intelligence. See all 7 Zen Component Grades here

2- Atlanticus Holdings (NASDAQ: ATLC)

This specialty fintech powerhouse — providing credit and financial services to underserved American consumers through its Credit as a Service and Auto Finance segments — just delivered a knockout Q1 2026. Earnings beat estimates thanks to organic growth and a winning M&A playbook, including the successful integration of Mercury and the Vive portfolio acquisition — a setup that has Wall Street piling in.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $84.75 — get current quote

Max 1-year forecast: $102.00

Why we're watching:

• Analyst support: The stock has 1 Strong Buy and 2 Buy ratings from 3 analysts, with an average price target of $100.00 representing 20.28% upside potential. See the ratings
• For example, B. Riley Securities' Hal Goetsch (a top 4% rated analyst) maintained his Strong Buy rating with a $98 price target following Q4 earnings. The analyst raised FY 2026 and 2027 EPS estimates to $8.48 and $11.53 respectively, attributing strong results to organic growth, accretion from the Mercury acquisition, and the Vive portfolio purchase, with ROE and EPS growth expected to exceed 20%.
• Citizens analyst David M. Scharf assigned the highest price target of $102, maintaining a Buy rating and underscoring the strong momentum in the business model and market opportunity.
• Industry ranking context: ATLC is currently the 1st highest-rated stock in the Credit Service industry, which has an Industry Rating of C, making Atlanticus the clear leader in its sector.
• Zen Rating highlights: With its overall A rating, a Strong Buy recommendation, ATLC demonstrates solid fundamentals based on our 115-factor review, landing the stock in a class of historical outperformers. 
• Component Grades: The company earned an A in Sentiment reflecting strong analyst confidence, B in Value, B in Growth with 32.17% earnings growth expected, and B in Financials with strong operating cash flow of $286.3M demonstrating robust cash generation capabilities. (See all 7 Zen Component Grades here)

3- Micron Technology (NASDAQ: MU)

The global memory and storage giant — operating across Compute and Networking, Mobile, Storage, and Embedded business units — is riding the AI revolution to spectacular gains. MU has surged over 900% from its 52-week low, and with CEO Sanjay Mehrotra's bullish commentary fueling $1,000 price speculation as AI-driven memory demand explodes, this name has become Wall Street's go-to DRAM play.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $923.52 — get current quote

Max 1-year forecast: $1,625.00

Why we're watching:

• Analyst support: Micron enjoys exceptional Wall Street backing with 19 Strong Buy ratings, 7 Buy ratings, and only 1 Hold rating among 27 analysts covering the stock—zero Sell or Strong Sell ratings. See the ratings
• Melius Research's Ben Reitzes (a top 11% rated analyst) maintains the street-high price target of $1,100, expressing bullish sentiment driven by market trends favoring DRAM and predicting significant upside as the memory market recovers.
• In addition to analysts, MU ranks highly in the eyes of our Zen Investor Editor-in-Chief Steve Reitmeister, who calls MU a Buy despite the stock already gaining 200%+ since it was added to his stock-picking portfolio in December 2025. See the full portfolio here
• Industry ranking context: Micron is currently the #1 highest-rated stock in the Semiconductor industry, which carries a B Industry Rating among 67 companies, underscoring its leadership position in a critically important sector.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — Micron ranks in the top 82nd percentile of all tracked stocks, reflecting its exceptional momentum and growth trajectory.
• Component Grades: Micron demonstrates exceptional performance with A grades in Growth, Momentum, and Financials and B grades in Value and Sentiment, while posting strong sentiment at the 75th percentile despite a D in Safety reflecting the stock's high beta of 1.8. See all 7 Zen Component Grades here

4- Tactile Systems Technology (NASDAQ: TCMD)

This innovative medical technology leader behind breakthrough devices for treating chronic diseases like lymphedema and chronic venous insufficiency is firing on all cylinders. With expanding product lines, growing market reach, and strong technological advantages, TCMD is positioned to capture significant additional market share in an underserved healthcare niche.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $25.55 — get current quote

Max 1-year forecast: $42.00

Why we're watching:

• Analyst support: All 3 analysts covering TCMD rate it a Strong Buy, with an average price target of $39.33 representing about 57% upside potential, and a max price target that suggests over 60% upside potential in the coming year. See the ratings
• For example, BTIG's Ryan Zimmerman (a top 17% rated analyst) recently reiterated his Strong Buy rating with a $40 price target, citing the company's successful market expansion and innovative product offerings that are driving strong customer adoption and capturing market share.
• Meanwhile, Piper Sandler analyst maintained a Strong Buy rating with the highest price target of $42, noting ongoing improvements in supply chain efficiencies paired with increased demand signal a robust financial outlook for the company.
• Industry ranking context: TCMD is currently the 6th highest-rated stock in the Medical Device industry, which has an Industry Rating of C, making TCMD stand out as a top performer in its sector.
• Zen Rating highlights: TCMD earns an overall A or Strong Buy recommendation. This means it ranks in the top 5% of stocks we track based on a 115-factor fundamental review — no small feat. 
• Component Grades: The company earned a B in Value, B in Safety, and B in Financials, reflecting solid fundamentals with a healthy debt-to-equity ratio of just 0.25 and strong cash flow generation of $42.06M in operating cash flow. (See all 7 Zen Component Grades here)

A note from our sponsors...

5- Orion Group (NYSE: ORN)

This marine and concrete construction powerhouse — serving the infrastructure, industrial, and building sectors both on and off the water across the U.S., Canada, and the Caribbean — is firing on all cylinders. Strong demand in marine infrastructure projects combined with strategic acquisitions is positioning ORN for multi-year growth that Wall Street is paying serious attention to.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $14.34 — get current quote

Max 1-year forecast: $19.00

Why we're watching:

• Analyst support: All 4 analysts covering ORN rate it a Strong Buy, demonstrating unanimous bullish sentiment. See the ratings
• For example, B. Riley Securities' Alex Rygiel (a top 2% rated analyst) recently maintained his Strong Buy rating following the company's Q4 earnings beat. The quarter's $233.2M in contract revenue and $13M adjusted EBITDA both surpassed consensus estimates, while an early Q1 $86.3M U.S. Army Corps project highlights momentum in Marine capabilities.
• Industry ranking context: ORN is currently the 2nd highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
• Zen Rating highlights: ORN has an A or Strong Buy recommendation from our Zen Ratings, putting it in a class of stocks that have historically trounced the S&P. 
• Component Grades: The company earned a B in Sentiment, reflecting positive analyst momentum, while the A in Growth highlights strong earnings forecasts with revenue expected to grow from $879.91M to $1.0B over two years. (See all 7 Zen Component Grades here)

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.